These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8398260)

  • 1. Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy.
    Friedl A; Jordan VC; Pollak M
    Eur J Cancer; 1993; 29A(10):1368-72. PubMed ID: 8398260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
    Pritchard KI; Shepherd LE; Chapman JA; Norris BD; Cantin J; Goss PE; Dent SF; Walde D; Vandenberg TA; Findlay B; O'Reilly SE; Wilson CF; Han L; Piura E; Whelan TJ; Pollak MN
    J Clin Oncol; 2011 Oct; 29(29):3869-76. PubMed ID: 21911723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of tamoxifen, aminoglutethimide and goserelin on human plasma IGF-I levels in breast cancer patients.
    Lien EA; Johannessen DC; Aakvaag A; Lønning PE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):541-3. PubMed ID: 1532904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen.
    Lahti EI; Knip M; Laatikainen TJ
    Cancer; 1994 Jul; 74(2):618-24. PubMed ID: 7518340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
    De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma.
    Ingle JN; Suman VJ; Kardinal CG; Krook JE; Mailliard JA; Veeder MH; Loprinzi CL; Dalton RJ; Hartmann LC; Conover CA; Pollak MN
    Cancer; 1999 Mar; 85(6):1284-92. PubMed ID: 10189133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients.
    Lønning PE; Hall K; Aakvaag A; Lien EA
    Cancer Res; 1992 Sep; 52(17):4719-23. PubMed ID: 1380889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen alters levels of serum insulin-like growth factors and binding proteins in postmenopausal breast cancer patients: a prospective paired cohort study.
    Ho GH; Ji CY; Phang BH; Lee KO; Soo KC; Ng EH
    Ann Surg Oncol; 1998 Jun; 5(4):361-7. PubMed ID: 9641459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF status is altered by tamoxifen in patients with breast cancer.
    Campbell MJ; Woodside JV; Secker-Walker J; Titcomb A; Leathem AJ
    Mol Pathol; 2001 Oct; 54(5):307-10. PubMed ID: 11577172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
    Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G
    Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Christie hospital adjuvant tamoxifen trial--status at 10 years.
    Ribeiro G; Swindell R
    Br J Cancer; 1988 Jun; 57(6):601-3. PubMed ID: 3044432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer.
    Reed MJ; Christodoulides A; Koistinen R; Seppälä M; Teale JD; Ghilchik MW
    Int J Cancer; 1992 Sep; 52(2):208-12. PubMed ID: 1381703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
    Jordan VC; Fritz NF; Tormey DC
    Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
    Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
    Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients.
    Helle SI; Holly JM; Tally M; Hall K; Vander Stappen J; Lønning PE
    Int J Cancer; 1996 Aug; 69(4):335-9. PubMed ID: 8797879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent.
    Jordan VC; Fritz NF; Langan-Fahey S; Thompson M; Tormey DC
    J Natl Cancer Inst; 1991 Oct; 83(20):1488-91. PubMed ID: 1920495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring IGF-1, ER-α and EGFR expression can predict tamoxifen-resistance in ER-positive breast cancer.
    Chong K; Subramanian A; Sharma A; Mokbel K
    Anticancer Res; 2011 Jan; 31(1):23-32. PubMed ID: 21273576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tamoxifen on plasma insulin-like growth factor I in patients with breast cancer.
    Colletti RB; Roberts JD; Devlin JT; Copeland KC
    Cancer Res; 1989 Apr; 49(7):1882-4. PubMed ID: 2924327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients.
    Pollak M; Costantino J; Polychronakos C; Blauer SA; Guyda H; Redmond C; Fisher B; Margolese R
    J Natl Cancer Inst; 1990 Nov; 82(21):1693-7. PubMed ID: 2231756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.